The identification of pyrazolo[1,5-a]pyridines as potent p38 kinase inhibitors
摘要:
A series of pyrazolo[1,5-a]pyridine derivatives was designed and synthesized as novel potent p38 kinase inhibitors. Our approaches towards improving in vitro metabolism and in vivo pharmacokinetic properties of the series are described. (C) 2008 Elsevier Ltd. All rights reserved.
Fused pyrazole derivatives being protein kinase inhibitors
申请人:Glaxo Group Limited
公开号:US07166597B2
公开(公告)日:2007-01-23
Compounds of Formula (I): salts or solvates or physiologically functional derivatives thereof, wherein Z is CH or N, and R1, R2, and R4 are various substituent groups, are protein kinase inhibitors
FUSED PYRAZOLE DERIVATIVES BEING PROTEIN KINASE INHIBITORS
申请人:GLAXO GROUP LIMITED
公开号:EP1311507B1
公开(公告)日:2006-03-01
US7166597B2
申请人:——
公开号:US7166597B2
公开(公告)日:2007-01-23
[EN] FUSED PYRAZOLE DERIVATIVES BEING PROTEIN KINASE INHIBITORS<br/>[FR] DERIVES DE PYRAZOLE A STRUCTURE FUSIONNEE TENANT LIEU D'INHIBITEURS DE PROTEINE KINASE
申请人:GLAXO GROUP LTD
公开号:WO2002016359A1
公开(公告)日:2002-02-28
Compounds of Formula (I): salts or solvates or physiologically functional derivatives thereof, wherein Z is CH or N, and R?1, R2, and R4¿ are various substituent groups, are protein kinase inhibitors.
Fused pyrazole derivatives bieng protein kinase inhibitors
申请人:——
公开号:US20040053942A1
公开(公告)日:2004-03-18
Compounds of Formula (I): salts or solvates or physiologically functional derivatives thereof, wherein Z is CH or N, and R
1
, (R
2
, and R
4
are various substituent groups, are protein kinase inhibitors.
1